According to the current analysis of Reports and Data, the ELISpot Assay Market was valued at USD 123.5 million in 2018 and is expected to reach USD 408.8 million by the year 2026, at a CAGR of 15.9%. ELISpot, also known as Enzyme-linked immune absorbent spot and Fluorospot, are assay methods used to detect cytokine secretion in samples, including blood plasma, serum, tissues, and...